F.L. Putnam Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.83M | Sell |
14,882
-337
| -2% | -$189K | 0.09% | 168 |
|
|
2026
Q1 | $8.55M | Sell |
15,219
-201
| -1% | -$129K | 0.13% | 136 |
|
|
2025
Q4 | $10.4M | Sell |
15,420
-56
| -0.4% | -$38.1K | 0.15% | 118 |
|
|
2025
Q3 | $9.89M | Sell |
15,476
-233
| -1% | -$141K | 0.15% | 121 |
|
|
2025
Q2 | $8.43M | Sell |
15,709
-526
| -3% | -$252K | 0.14% | 135 |
|
|
2025
Q1 | $6.82M | Sell |
16,235
-359
| -2% | -$156K | 0.13% | 134 |
|
|
2024
Q4 | $6.86M | Sell |
16,594
-177
| -1% | -$77.6K | 0.13% | 136 |
|
|
2024
Q3 | $8.47M | Sell |
16,771
-1,120
| -6% | -$544K | 0.15% | 126 |
|
|
2024
Q2 | $8.72M | Sell |
17,891
-212
| -1% | -$106K | 0.16% | 123 |
|
|
2024
Q1 | $9.77M | Buy |
18,103
+56
| +0.3% | +$30.6K | 0.21% | 99 |
|
|
2023
Q4 | $10M | Sell |
18,047
-93
| -0.5% | -$43.7K | 0.24% | 95 |
|
|
2023
Q3 | $7.93M | Buy |
18,140
+10,468
| +136% | +$5.22M | 0.22% | 98 |
|
|
2023
Q2 | $3.85M | Sell |
7,672
-45
| -0.6% | -$21.6K | 0.1% | 157 |
|
|
2023
Q1 | $3.86M | Buy |
7,717
+137
| +2% | +$65.6K | 0.13% | 139 |
|
|
2022
Q4 | $3.09M | Sell |
7,580
-308
| -4% | -$120K | 0.11% | 138 |
|
|
2022
Q3 | $2.57M | Sell |
7,888
-40
| -0.5% | -$14.7K | 0.1% | 148 |
|
|
2022
Q2 | $2.78M | Sell |
7,928
-55
| -0.7% | -$22.4K | 0.1% | 149 |
|
|
2022
Q1 | $4.37M | Sell |
7,983
-183
| -2% | -$96.3K | 0.14% | 129 |
|
|
2021
Q4 | $5.38M | Sell |
8,166
-115
| -1% | -$72.2K | 0.16% | 113 |
|
|
2021
Q3 | $5.15M | Sell |
8,281
-6
| -0.1% | -$4.03K | 0.17% | 111 |
|
|
2021
Q2 | $5.23M | Buy |
8,287
+1,182
| +17% | +$653K | 0.18% | 108 |
|
|
2021
Q1 | $3.48M | Sell |
7,105
-56
| -0.8% | -$28.1K | 0.15% | 120 |
|
|
2020
Q4 | $3.58M | Hold |
7,161
| – | – | 0.17% | 108 |
|
|
2020
Q3 | $2.81M | Sell |
7,161
-315
| -4% | -$116K | 0.15% | 105 |
|
|
2020
Q2 | $2.47M | Buy |
7,476
+128
| +2% | +$37.1K | 0.15% | 107 |
|
|
2020
Q1 | $1.78M | Sell |
7,348
-526
| -7% | -$137K | 0.14% | 117 |
|
|
2019
Q4 | $2.06M | Buy |
7,874
+36
| +0.5% | +$9.49K | 0.13% | 125 |
|
|
2019
Q3 | $2.13M | Buy |
7,838
+97
| +1% | +$27K | 0.15% | 115 |
|
|
2019
Q2 | $2.13M | Sell |
7,741
-15
| -0.2% | -$3.7K | 0.17% | 106 |
|
|
2019
Q1 | $1.73M | Hold |
7,756
| – | – | 0.15% | 107 |
|
|
2018
Q4 | $1.44M | Buy |
7,756
+2,907
| +60% | +$596K | 0.16% | 109 |
|
|
2018
Q3 | $1.21M | Hold |
4,849
| – | – | 0.11% | 131 |
|
|
2018
Q2 | $1.06M | Hold |
4,849
| – | – | 0.1% | 135 |
|
|
2018
Q1 | $928K | Hold |
4,849
| – | – | 0.08% | 142 |
|
|
2017
Q4 | $758K | Hold |
4,849
| – | – | 0.07% | 152 |
|
|
2017
Q3 | $754K | Buy |
+4,849
| New | +$767K | 0.07% | 154 |
|
|
2017
Q1 | $836K | Hold |
5,410
| – | – | 0.09% | 142 |
|
|
2016
Q4 | $634K | Sell |
5,410
-50
| -0.9% | -$5.71K | 0.07% | 138 |
|
|
2016
Q3 | $616K | Sell |
5,460
-65
| -1% | -$6.85K | 0.07% | 134 |
|
|
2016
Q2 | $513K | Hold |
5,525
| – | – | 0.06% | 129 |
|
|
2016
Q1 | $433K | Buy |
5,525
+135
| +3% | +$9.72K | 0.05% | 130 |
|
|
2015
Q4 | $393K | Sell |
5,390
-450
| -8% | -$32.1K | 0.05% | 137 |
|
|
2015
Q3 | $434K | Sell |
5,840
-120
| -2% | -$8.6K | 0.05% | 136 |
|
|
2015
Q2 | $382K | Sell |
5,960
-878
| -13% | -$60.8K | 0.04% | 146 |
|
|
2015
Q1 | $528K | Sell |
6,838
-120
| -2% | -$9.34K | 0.06% | 133 |
|
|
2014
Q4 | $516K | Sell |
6,958
-130
| -2% | -$9.12K | 0.06% | 141 |
|
|
2014
Q3 | $418K | Buy |
7,088
+50
| +0.7% | +$3.16K | 0.05% | 150 |
|
|
2014
Q2 | $470K | Hold |
7,038
| – | – | 0.05% | 153 |
|
|
2014
Q1 | $427K | Buy |
7,038
+386
| +6% | +$23K | 0.05% | 161 |
|
|
2013
Q4 | $354K | Sell |
6,652
-500
| -7% | -$26.3K | 0.04% | 167 |
|
|
2013
Q3 | $356K | Sell |
7,152
-400
| -5% | -$19.2K | 0.05% | 167 |
|
|
2013
Q2 | $339K | Buy |
+7,552
| New | +$330K | 0.05% | 159 |
|
Other funds holding IDXX
MBI
CGI
F.L. Putnam Investment Management's IDXX Position: Q2 2026 in Review
F.L. Putnam Investment Management reduced its Idexx Laboratories (IDXX) stake by 2.2% in Q2 2026, selling an estimated $189K and leaving 14,882 shares worth $7.83M. The position accounts for 0.09% of the portfolio, ranked #168.
F.L. Putnam Investment Management first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.4M in Q4 2025. 773 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- F.L. Putnam Investment Management held 14,882 shares of Idexx Laboratories worth $7.83M as of Q2 2026.
- F.L. Putnam Investment Management sold 337 Idexx Laboratories shares in Q2 2026, an estimated $189K.
- Idexx Laboratories made up 0.09% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #168 holding.
- F.L. Putnam Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
- F.L. Putnam Investment Management's Idexx Laboratories position peaked at $10.4M in Q4 2025.
- 773 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.